The diagnostic efficiency of IgA anti-β2-GP1 was evaluated according to the ROC curves (Figure 4) depending on the presence of thrombosis, pregnancy morbidity, and a confirmed diagnosis of APS. This evidence concerns the gene CD79A and deep vein thrombosis.